Information  X 
Enter a valid email address

Lekoil Limited (LEK)


Tuesday 14 June, 2022

Lekoil Limited

Operational update

RNS Number : 8351O
Lekoil Limited
14 June 2022




14 June 2022

Lekoil Limited

("LEKOIL" or the "Company")


Operational update


LEKOIL (AQSE: LEK), the Cayman Islands litigation asset company with an investment in oil & gas assets in Nigeria,

is pleased to provide the following operational update. 


Operational Development for the month of May 2022 taken from information provided by Lekoil Nigeria

· Otakikpo:

Oil production in May 2022 of 4,230 bopd (gross)/1,692 bopd (net).

Drilling of Otakikpo-4 continued during the month.

· OPL 310 (Ogo):

No material update.

· OPL 325:

No material update.

· OPL 276

No material update.




The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.


For further information, please visit or contact:

First Sentinel Corporate Finance Ltd (AQSE Corporate Adviser)

Brian Stockbridge


+44 203 989 2200

Tennyson Securities (Broker)

Peter Krens

+44 20 7186 9030

Camarco (Financial PR Advisor)     

Billy Clegg / Owen Roberts / Violet Wilson

+44 20 3757 4983


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t